Treatment of Older Patients with Chronic Lymphocytic Leukemia

Toward chemotherapy-free treatment of CLL

(2011) S. Stilgenbauer et al.   BLOOD

Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL)

(2010) H. V. MARQUART et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

(2010) M Hallek et al.   LANCET

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

(2009) B. F. Eichhorst et al.   BLOOD

Treatment of elderly patients with chronic lymphocytic leukemia

(2009) Barbara Eichhorst et al.   LEUKEMIA & LYMPHOMA

Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: Molecular Remissions Predict for Durable Complete Responses

(2008) Nicole Lamanna et al.   JOURNAL OF CLINICAL ONCOLOGY